Published in Medical Letter on the CDC and FDA, May 2nd, 2004
"Physicians, now more than ever, need a new therapeutic option to treat their patients suffering from mild to moderate RTIs,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA